Biocon Limited (BIOCON) Stock Statistics & Valuation Metrics

Biocon Limited has a market cap or net worth of ₹529.57B. The enterprise value is ₹672.37B.

Biocon Limited has 1,336,963,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biocon Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 9.93%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Biocon Limited had revenue of 150.52B and earned 10.13B in profits. Earnings per share was 8.46.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Biocon Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.13%

Biocon Limited upcoming earnings date is Aug 7, 2025, TBA (Confirmed).

Biocon Limited as a current ratio of 0.99, with Debt / Equity ratio of 84.84%

In the past 12 months, Biocon Limited has paid 4.57B in taxes.

Biocon Limited EV to EBITDA ratio is 11.39, with an EV/FCF ratio of 46.27.

Biocon Limited has ₹50.23B in cash and marketable securities with ₹183.62B in debt, giving a net cash position of ₹133.39B billion.

Gross margin is 58.39%, with operating margin of 34.45%, and net profit margin of 6.93%.

The average price target for Biocon Limited is ₹390.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy